| Entry |
|
| Name |
Leridistim (USAN/INN)
|
| Formula |
C1550H2463N425O462S12
|
| Exact mass |
34806.8949
|
| Mol weight |
34828.4915
|
| Sequence |
ANCSNMIDEI ITHLKQPPLP LLDFNNLNGE DQDILMDNNL RRPNLEAFNR AVKSLQNASA IESILKNLLP CLPLATAAPT RHPIHIKDGD WNEFRRKLTF YLKTLENAQA QQYVEGGGGS PGEPSGPIST INPSPPSKES HKSPNMATPL GPASSLPQSF LLKSLEQVRK IQGDGAALQE KLCATYKLCH PEELVLLGHS LGIPWAPLSS CPSQALQLAG CLSQLHSGLF LYQGLLQALE GISPELGPTL DTLQLDVADF ATTIWQQMEE LGMAPALQPT QGAMPAFASA FQRRAGGVLV ASHLQSFLEV SYRVLRHLAQ P |
| Type |
Peptide |
| Activity |
Treatment of chemotherapy-induced neutropenia and thrombocytopenia [multifunctional agonist that activates both interleukin-3 and G-CSF receptors]
|
| Target |
granulocyte colony stimulating factor (G-CSF) receptor agonist [HSA: 1441] [KO: K05061]; interleukin-3 (IL-3) receptor agonist [HSA: 3563] [KO: K04737] |
| Pathway |
|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokine receptors
Class I cytokine receptors (hematopoietin family receptors)
interleukin 3 receptor [HSA:3563] [KO:K04737]
Leridistim
D04695 Leridistim (USAN/INN)
granulocyte colony stimulating factor (G-CSF) receptor [HSA:1441] [KO:K05061]
Leridistim
D04695 Leridistim (USAN/INN)
 |
| Other DBs |
|